Copyright
©The Author(s) 2020.
World J Hepatol. Sep 27, 2020; 12(9): 596-618
Published online Sep 27, 2020. doi: 10.4254/wjh.v12.i9.596
Published online Sep 27, 2020. doi: 10.4254/wjh.v12.i9.596
Figure 2 Administration of glycyrrhizin at the same time as acetaminophen, reduced the severity of liver injury.
A: Alanine aminotransferase (ALT) levels were measured after 12 h in the plasma of mice treated by vehicle or glycyrrhizin (GL) at the time of acetaminophen (APAP) injection (10 mice in each group); B: Aspartate aminotransferase (AST) levels were measured after 12 h in the plasma of mice treated by vehicle or GL at the time of APAP injection (10 mice in each group) C: Lactate dehydrogenase (LDH) levels were measured after 12 h in the plasma of mice treated by vehicle or GL at the time of APAP injection (10 mice in each group); D: Liver necrosis was scored in the same group of mice; E: Representative hematoxylin and eosin (H&E; magnification × 200) and high mobility group box 1 (HMGB1)-stained images (magnification × 400) of murine liver 12 h after APAP challenge in the same group of mice; F: HMGB1 levels were measured in the same group of mice; G: Quantification of nuclear expression of HMGB1 in the same groups of mice. Results are expressed as mean ± standard error. cP < 0.05, dP < 0.01, eP < 0.001 vs APAP. Experiments were reproduced three times.
- Citation: Minsart C, Rorive S, Lemmers A, Quertinmont E, Gustot T. N-acetylcysteine and glycyrrhizin combination: Benefit outcome in a murine model of acetaminophen-induced liver failure. World J Hepatol 2020; 12(9): 596-618
- URL: https://www.wjgnet.com/1948-5182/full/v12/i9/596.htm
- DOI: https://dx.doi.org/10.4254/wjh.v12.i9.596